Review Article
[Retracted] Influence of Two Common Polymorphisms in the EPHX1 Gene on Warfarin Maintenance Dosage: A Meta-Analysis
Table 2
Meta-analysis of the associations between EPHX1 rs2292566 G>A polymorphism and warfarin maintenance dosage.
| | GG versus AA | GG versus GA | GA versus AA | | SMD | 95% CI | | | | SMD | 95% CI | | | | SMD | 95% CI | | | |
| Overall | 0.76 | 0.47~1.05 | <0.001 | 0.699 | 0.0% | 0.43 | 0.03~0.83 | 0.035 | <0.001 | 87.6% | 0.31 | −0.15~0.76 | 0.186 | 0.105 | 47.7% | Ethnicity | | | | | | | | | | | | | | | | Caucasians | 0.52 | 0.07~1.03 | 0.006 | 0.716 | 0.0% | 0.28 | 0.07~0.49 | 0.009 | 0.550 | 0.0% | 0.40 | −0.25~1.06 | 0.226 | 0.028 | 72.0% | Asians | 0.84 | −0.13~1.15 | 0.699 | 0.895 | 0.0% | 0.54 | −0.14~1.23 | 0.122 | <0.001 | 92.6% | 0.05 | −0.72~0.82 | 0.898 | 0.830 | 0.0% | Sample size | | | | | | | | | | | | | | | | Small () | 0.71 | −0.01~1.10 | 0.310 | 0.462 | 0.0% | 0.24 | −0.13~0.60 | 0.210 | 0.058 | 64.8% | −0.05 | −0.46~0.36 | 0.815 | 0.724 | 0.0% | Large () | 0.82 | 0.40~1.24 | <0.001 | 0.479 | 0.0% | 0.67 | 0.01~1.34 | 0.042 | <0.001 | 93.0% | 0.62 | 0.17~1.07 | 0.007 | 0.334 | 8.7% | Genotyping method | | | | | | | | | | | | | | | | TaqMan assay | 0.78 | 0.02~1.03 | 0.465 | 0.716 | 0.0% | 0.28 | 0.07~0.49 | 0.009 | 0.550 | 92.6% | 0.40 | −0.25~1.06 | 0.226 | 0.028 | 72.0% | Non-TaqMan assay | 0.84 | 0.00~1.15 | 0.051 | 0.895 | 0.0% | 0.54 | −0.14~1.23 | 0.122 | <0.001 | 0.0% | 0.05 | −0.72~0.82 | 0.898 | 0.830 | 0.0% |
|
|
EPHX1: epoxide hydrolase 1; SMD: standardized mean difference; 95% CI: 95% confidence interval; : the value for the heterogeneity test.
|